Do heart transplant recipients need annual coronary angiography?

eheart failure, myocardial infarction or sudden death as initial clinical manifestations of disease[8]. dependent on the heart rate response for its effects and thus appears well suited for use in conjunctionThe fact that only 50 % of transplant recipients have angiographically recognizable disease 5 years after transplantation[2] indicates that annual routine angiography may not be the optimal way of following with perfusion scintigraphy in transplant patients. However, dipyridamole in conjunction with thallium perfusion imaging yielded low sensitivities of 21%[10] and 58%[15]. This could, however, have been causedEuropean Heart Journal (2001) 22, 895–897 doi:10.1053/euhj.2001.2660, available online a